ACTIVE_NOT_RECRUITING

Impact of Financial Incentives

Talk to us

Conditions

Human Papilloma Virusfinancial incentivespediatric medicinevaccinationpay-for-performance

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.

Official Title

The Impact of Clinic-level Financial Incentives on HPV Vaccine Communication and Uptake

Quick Facts

Study Start:2023-02-28
Study Completion:2026-08-29
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05744960

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:9 Years to 12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * less than 72% HPV vaccine initiation rate,
  2. * greater than or equal to 50 patients ages 9-12
  3. * greater than or equal to 2 HPV vaccine providers
  4. * no clinic or provider-level financial incentive programs to increase system, clinic, or provider HPV vaccination rates among patients aged 9-12 in the past two years, and
  5. * no HPV vaccine provider communication trainings in the past six months.
  6. * are between the ages of 9-12 years at baseline and
  7. * are attributed to a participating clinic at 12- or 24-month follow-up.
  1. * do not provide HPV vaccine to children ages 9-12
  2. * have a specialty other than pediatrics or family medicine
  3. * had an HPV vaccine-specific financial incentive program in the past two years
  4. * had a formal HPV vaccine communication training in the past 6 months
  5. * had an HPV initiation rate greater than 72$
  6. * had fewer than 49 patients aged 9-12
  7. * had 1 or fewer HPV vaccine providers
  8. * are not between the ages of 9-12 years at baseline
  9. * are not attributed to a participating clinic at 12- or 24-month follow-up

Contacts and Locations

Principal Investigator

Justin G Trogdon, PhD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill

Study Locations (Sites)

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599-7590
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Justin G Trogdon, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-28
Study Completion Date2026-08-29

Study Record Updates

Study Start Date2023-02-28
Study Completion Date2026-08-29

Terms related to this study

Keywords Provided by Researchers

  • financial incentives
  • pediatric medicine
  • vaccination
  • pay-for-performance

Additional Relevant MeSH Terms

  • Human Papilloma Virus